Lung Cancer Patients with Minimally Invasive Adenocarcinoma Have ...
Newswise — Chicago, October 30, 2014—Lung cancer patients with minimally invasive adenocarcinoma (MIA) have similar, positive five-year disease-free survival (DFS) and overall survival (OS) rates as patients with adenocarcinoma in-situ (AIS ...
Newswise (press release) - Thu, 30 Oct 2014 06:07

Lung cancer patients with MIA have comparable 97.7 percent five-year survival ...
Lung cancer patients with minimally invasive adenocarcinoma (MIA) have similar, positive five-year disease-free survival (DFS) and overall survival (OS) rates as patients with adenocarcinoma in-situ (AIS), according to research presented today at the ...
Medical Xpress - Thu, 30 Oct 2014 08:33

Inflammatory biomarkers may signal higher risk of esophageal adenocarcinoma
Identifying individuals at increased risk of progressing from Barrett's esophagus to esophageal adenocarcinoma could greatly improve outcomes through earlier detection. Inflammatory biomarkers have been used to help predict onset of other cancers, but ...
Fred Hutchinson Cancer Research Center News - Mon, 20 Oct 2014 14:11



UK tops global league table for gullet cancer -- adenocarcinoma -- in men
Rates of SCC have remained fairly stable or have even fallen over the past few years, but those of adenocarcinoma have risen, particularly in high income countries. In 2012, oesophageal cancer was the eighth most common cancer worldwide.
EurekAlert (press release) - Wed, 15 Oct 2014 15:30

UK men have highest risk of oesophageal cancer in the world
OnMedica - Thu, 16 Oct 2014 03:07

UK tops WHO gullet cancer table and obesity may be factor
BBC News - Wed, 15 Oct 2014 17:13

UK men at highest risk for type of gullet cancer
WebMD.Boots.com - Wed, 15 Oct 2014 23:18

Men at fourfold higher risk for esophageal adenocarcinoma
Men, particularly those with adenocarcinoma, have a significantly higher risk for developing esophageal cancer compared with women worldwide, with a fourfold greater risk globally and an eightfold greater risk in North America, according to new global ...
Healio - Fri, 17 Oct 2014 11:33

Platinum-based chemotherapy extended OS in BRCA-associated pancreatic ...
Patients with advanced BRCA-associated pancreatic ductal adenocarcinoma treated with platinum-based chemotherapy experienced longer OS than those who received non-platinum therapy, according to study results.
Healio - Tue, 07 Oct 2014 01:18

ASCO: Offer EGFR, ALK testing to all patients with lung adenocarcinoma
ASCO today endorsed a joint clinical practice guideline from three other entities that addresses questions about the appropriate use of EGFR-mutation and ALK-rearrangement testing in patients with lung cancer.
Healio - Mon, 13 Oct 2014 13:05



Customising chemotherapy in Lu Ca: New Ph II data reported in 2 LB studies
"Our results show a statistical improvement in overall survival and a promising progression-free survival signal with vintafolide and docetaxel for advanced lung adenocarcinoma patients selected by an imaging biomarker for the folate receptor. These ...
EurekAlert (press release) - Sat, 27 Sep 2014 07:03

Vintafolide Added to Docetaxel Improves Survival in Folate Receptor-Positive ...
OncLive - Sun, 28 Sep 2014 09:30

Endocyte (ECYT) Presents Positive Data from TARGET Phase 2b
StreetInsider.com (subscription) - Mon, 29 Sep 2014 03:14

Endocytes TARGET Interim Data Positive for Lung Cancer
Zacks.com - Mon, 29 Sep 2014 13:31


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014